PAYD · Paid Inc · Share Buybacks
The latest filing states the doubt was alleviated.
“Management believes that the Company has adequate cash resources to fund operations during the next 12 months after the filing of this quarterly report on Form 10-Q. The repayment of the Embolx note receivable will alleviate the concern however the repayment date is uncertain. Additionally, the costs of doing business can be significantly reduced in hopes of eliminating the net loss and continuing to provide positive cash flow from operations.”View the 10-Q filed Aug 14, 2026
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $0 | 10-K, filed 2026-03-31 |
| 2024-12-31 | $3,996 | 10-K, filed 2026-03-31 |
| 2023-12-31 | $0 | 10-K, filed 2025-04-15 |
| 2022-12-31 | $106,993 | 10-K, filed 2024-04-01 |
| 2021-12-31 | $0 | 10-K, filed 2023-03-31 |
| 2018-12-31 | $0 | 10-K, filed 2019-04-01 |
| 2017-12-31 | $26,529 | 10-K, filed 2019-04-01 |
| 2016-12-31 | $0 | 10-K, filed 2018-03-30 |